Derek James Parks

Title: The Innovations of Derek James Parks

Introduction

Derek James Parks is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of nuclear receptors, holding a total of 2 patents. His work focuses on identifying ligands for nuclear receptors, which has important implications in various scientific applications.

Latest Patents

Derek's latest patents include innovative methods and assays. The first patent, titled "Use of FXR ligands," involves nuclear receptor heterodimer and nuclear receptor-coactivator peptide assays for identifying ligands for nuclear receptors. This invention utilizes scintillation proximity and fluorescence resonance energy transfer (FRET) to enhance the identification process. The second patent, "Constitutive Androstane Receptor," relates specifically to the Constitutive Androstane Receptor (CAR; NR 1I3) and outlines a method for identifying ligands for this important nuclear receptor.

Career Highlights

Derek is currently employed at SmithKline Beecham Corporation, where he continues to advance his research and development efforts. His work has contributed to the understanding of nuclear receptors and their potential applications in medicine and biotechnology.

Collaborations

Derek has collaborated with several talented individuals in his field, including Curt Dale Haffner and Patrick Reed Maloney. These collaborations have fostered a productive environment for innovation and discovery.

Conclusion

Derek James Parks is a distinguished inventor whose work in nuclear receptors has led to valuable patents and advancements in the field. His contributions continue to influence research and development in significant ways.